Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024

On August 7, 2023 JSR reported its Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024 (Presentation, JSR, AUG 7, 2023, View Source [SID1234634972]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!